Skip to main content
PMC home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2010 May 27;25(2):164–168. doi: 10.1007/s12291-010-0030-1

Biochemical and genetic studies on cardiometabolic syndrome

A Supriya Simon 1,✉, D Dinesh Roy 2, V Jayapal 3, T Vijayakumar 4
PMCID: PMC3453103  PMID: 23105904

Abstract

Cardiometabolic syndrome is one of the major public health issues of this century which describes a cluster of clinical characteristics. Seventy two patients with coronary artery disease (CAD) and cardiometabolic syndrome and forty healthy age and sex matched normal controls were selected for this study. Detailed clinical epidemiological and anthropometric characteristics were noted. Lipid profile and Cytokinesis-block micronuclei (CBMN) assay using cytochalasin B were carried out in all the subjects. Serum total cholesterol, triglyceride and LDL-cholesterol was significantly higher and HDL cholesterol was significantly lower in patients compared to their normal counter-parts (P<0.05). CBMN frequency of the patients was significantly higher at all ages compared to their normal counter parts (P<0.05). Various risk factors like diabetes, hypertension, dyslipidemia, abdominal obesity, smoking and alcoholism were found influenced the CBMN frequency; but the changes were not significant. From this study it can be concluded that DNA damage was found to be higher in patients with cardiometabolic syndrome which may be attributed to the generation of free radicals associated with alcohol consumption, tobacco use, dyslipidemia and glucose intolerance and the accumulation of free radicals with increase in age.

Key Words: Cardiometabolic syndrome, Metabolic syndrome, Coronary artery disease, DNA damage, Lipid profile, Cytokinesis-block micronuclei assay

Full Text

The Full Text of this article is available as a PDF (73.4 KB).

References

  • 1.Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–2752. doi: 10.1161/CIRCULATIONAHA.105.169404. [DOI] [PubMed] [Google Scholar]
  • 2.Govindarajan G., Whaley-Connell A., Mugo M., Stump C., Sowers J.R. The cardiometabolic syndrome as a cardiovascular risk factor. Am J Med Sci. 2005;330(6):311–318. doi: 10.1097/00000441-200512000-00009. [DOI] [PubMed] [Google Scholar]
  • 3.Pandey S., Baral N., Majhi S., Acharya P., Karki P., Shrestha S., et al. Prevalence of the metabolic syndrome in acute myocardial infarction and its impact on hospital outcomes. Int J Diab Dev Ctries. 2009;29:52–55. doi: 10.4103/0973-3930.53120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Frisard M.I., Rood J.C., Fang X., Su J., Welsh D.A., Jazwinski S.M., Ravussin E. Metabolic syndrome and risk factors for cardiovascular disease: are nonagenarians protected? Age (Dordr) 2009;31(1):67–75. doi: 10.1007/s11357-008-9082-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet. 2005;365:1415–1428. doi: 10.1016/S0140-6736(05)66378-7. [DOI] [PubMed] [Google Scholar]
  • 6.Andreassi M.G. Metabolic syndrome, diabetes and atherosclerosis: influence of gene-environment interaction. Mutat Res. 2009;667(1–2):35–43. doi: 10.1016/j.mrfmmm.2008.10.018. [DOI] [PubMed] [Google Scholar]
  • 7.Botto N., Mssetti S., Petrozzi L. Elevated levels of oxidative DNA damage in patients with coronary artery disease. Coron Artery Dis. 2002;13:269–274. doi: 10.1097/00019501-200208000-00004. [DOI] [PubMed] [Google Scholar]
  • 8.Andreassi M.G. Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage. Mutat Res. 2003;543:67–86. doi: 10.1016/S1383-5742(02)00089-3. [DOI] [PubMed] [Google Scholar]
  • 9.Demirbag R., Yilmaz R., Gur M., Celik H., Guzel S., Selek S., et al. DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements. Int J Clin Pract. 2006;60:1187–1193. doi: 10.1111/j.1742-1241.2006.01042.x. [DOI] [PubMed] [Google Scholar]
  • 10.Rifai N., Bachorik P.S., Albers J.J. Lipids,lipoprotein and apolipoprotein. In: Burtis C.A., Ashwood R., editors. Tietz textbook of clinical chemistry. 3rd ed. Philadelphia.: W.B. Saunders company; 1999. pp. 806–861. [Google Scholar]
  • 11.Mc Gowan M.W., Artiss J.D., Standbergh D.R., Zark B. A peroxidase coupled method for the colorimeteric determination of serum triglycerides. Clin Chem. 1983;29(3):538–542. [PubMed] [Google Scholar]
  • 12.Sugiuchi H., Uji Y., Okabe H., Irie T., Uekama K., Kayahara N., et al. Direct measurement of High-Density Lipoprotein Cholesterol in serum with polyethylene glycol-modified enzymes and sulphated alpha-cyclodextrin. Clin Chem. 1995;41:717–723. [PubMed] [Google Scholar]
  • 13.Armstrong V., Seidel D. Evaluation of a commercial kit for the determination of LDL-cholesterol in serum based on precipitation of LDL with dextran sulphate. Arztl Lab. 1985;31:325–330. [Google Scholar]
  • 14.Moorhead P.S., Nowell P.C., Mellman W.J., Battips D.M., Hungerford D.A. Chromosome preparations of leukocytes cultured from human peripheral blood. Exp Cell Res. 1960;20:613–616. doi: 10.1016/0014-4827(60)90138-5. [DOI] [PubMed] [Google Scholar]
  • 15.Fenech M. The cytokinesis-block micronucleus technique and its application to genotoxicity studies in human populations. Environmental Health Perspectives. 1993;101(3):101–107. doi: 10.2307/3431708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome in U.S. adults. JAMA. 2002;287:356–359. doi: 10.1001/jama.287.3.356. [DOI] [PubMed] [Google Scholar]
  • 17.Deepa M., Farooq S., Datta M., Deepa R., Mohan V. Prevalence of metabolic syndrome using WHO, ATP III, and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34) Diabetes Metab Res Rev. 2007;23:127–134. doi: 10.1002/dmrr.658. [DOI] [PubMed] [Google Scholar]
  • 18.Abbott R.D., Curb J.D., Rodriguez B.L., Masaki K.H., Yano K., Schatz I.J., et al. Age-related changes in risk factor effects on the incidence of coronary heart disease. Ann Epidemiol. 2002;12:173–181. doi: 10.1016/S1047-2797(01)00309-X. [DOI] [PubMed] [Google Scholar]
  • 19.Ghosh J., Mishra T. K., Rao Y. N., Aggarwal S. K. Oxidised LDL, HDL cholesterol, LDL cholesterol levels in patients of coronary artery disease. Ind J Clin Biochem. 2006;21:181–184. doi: 10.1007/BF02913092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Lahdenpera S., Syvanne M., Kahri J., Taskinen M.R. Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides. Diabetologia. 1996;39(4):453–461. doi: 10.1007/BF00400677. [DOI] [PubMed] [Google Scholar]
  • 21.Ishizaka N., Ishizaka Y., Toda E., Hashimoto H., Nagai R., Yamakado M. Association between cigarette smoking, metabolic syndrome, and carotid arteriosclerosis in Japanese individuals. Atherosclerosis. 2005;181:381–388. doi: 10.1016/j.atherosclerosis.2005.01.026. [DOI] [PubMed] [Google Scholar]
  • 22.Nakanishi N., Takatorige T., Suzuki K. Cigarette smoking and the risk of the metabolic syndrome in middle-aged Japanese male office workers. Ind Health. 2005;43:295–301. doi: 10.2486/indhealth.43.295. [DOI] [PubMed] [Google Scholar]
  • 23.Ramachandran A., Snehalatha C., Satyavani K., Weiss R., Dziura J., Burgert T.S. Metabolic syndrome in urban Asian Indian adults: a population study using modified ATP III criteria. Diabetes Res Clin Pract. 2003;60:199–204. doi: 10.1016/S0168-8227(03)00060-3. [DOI] [PubMed] [Google Scholar]
  • 24.Balkau B., Picard P., Vol S., Fezeu L., Eschwège E. Consequences of Change in Waist Circumference. Diabetes Care. 2007;30(7):1901–1903. doi: 10.2337/dc06-2542. [DOI] [PubMed] [Google Scholar]
  • 25.Wang Y., Rimm E.B., Stampfer M.J., Willett W.C., Hu F.B. Comparison of abdominal adiposity and overall obesity in predicing risk of Type 2 diabetes among man. Am J Clin Nutr. 2005;81:555–563. doi: 10.1093/ajcn/81.3.555. [DOI] [PubMed] [Google Scholar]
  • 26.Haffner S.M., Stern M.P., Hazuda H.P., Mitchell B.D., Patterson J.K. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA. 1990;263:2893–2898. doi: 10.1001/jama.263.21.2893. [DOI] [PubMed] [Google Scholar]
  • 27.McPhillips J.B., Barrett-Connor E., Wingard D.L. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol. 1990;131:443–453. doi: 10.1093/oxfordjournals.aje.a115519. [DOI] [PubMed] [Google Scholar]
  • 28.Mykkanen L., Kuusisto J., Pyorala K., Laakso M. Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in early subjects. Diabetologia. 1993;36:553–559. doi: 10.1007/BF02743273. [DOI] [PubMed] [Google Scholar]
  • 29.Zimmet P.Z., Alberti K.G.M.M. The changing face of macrovascular disease in non-insulin-dependent diabetes mellitus: an epidemic in progress. Lancet. 1997;350(1):1–4. doi: 10.1016/S0140-6736(97)90020-9. [DOI] [PubMed] [Google Scholar]
  • 30.Mahadik S.R., Deo S.S., Mehtalia S.D. Increased prevalence of metabolic syndrome in non-obese Asian Indian-an urban-rural comparison. Metab Syndr Relat Disord. 2007;5(2):142–152. doi: 10.1089/met.2006.0029. [DOI] [PubMed] [Google Scholar]
  • 31.Fan A.Z., Russell M., Dorn J., Freudenheim J.L., Nochajski T., Hovey K., et al. Lifetime alcohol drinking pattern is related to the prevalence of metabolic syndrome. The Western New York Health Study (WNYHS) Eur J Epidemiol. 2006;21:129–138. doi: 10.1007/s10654-005-5457-y. [DOI] [PubMed] [Google Scholar]
  • 32.Wei-ju L., Hao X., Kai S., Xiao-dong S., Yi-bo W., Yi-song Z., et al. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria. Chin Med J. 2008;121:1532–1536. [PubMed] [Google Scholar]
  • 33.Nishtha J., Imrana N., Jamal A. Evaluation of DNA damage and metabolic syndrome parameters in diabetic rabbits supplemented with antioxidants. Fundamental Clin Pharmacol. 2009;23:197–205. doi: 10.1111/j.1472-8206.2009.00666.x. [DOI] [PubMed] [Google Scholar]
  • 34.Satoh M., Ishikawa Y., Takahashi Y., Itoh T., Minami Y., Nakamura M. Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis. 2008;198(2):347–353. doi: 10.1016/j.atherosclerosis.2007.09.040. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES